{"Name":"Raven Biotechnologies","perma":"raven-biotechnologies","BasicInfo":{"funded":"1999-01-01","isClosed":false,"closed":null,"short":"Raven biotechnologies is focused on the development of monoclonal antibody therapeutics for the treatment of cancer."},"FundingRounds":[{"funding_type":"venture","series":"D","announcedDate":"2005-10-24","moneyRaised":48300000},{"funding_type":"venture","series":"C","announcedDate":"2003-01-03","moneyRaised":40000000}],"Acquisitions":[],"AcquiredBy":{"price":null,"paymentType":null,"announcedDate":"2008-07-17","completedDate":null,"acquisitionType":null,"acquirer":"MacroGenics"},"IPO":null,"Investments":[],"Products":[],"CurrentTeam":[],"PastTeam":[{"title":"COO","started":"2002-01-01","ended":"2008-01-01","firstName":"John","lastName":"B. Whelan"},{"title":"President and Chief Financial Officer","started":null,"ended":null,"firstName":"Shirley","lastName":"Clayton"},{"title":"Founder / CEO","started":"2002-01-01","ended":"2008-01-01","firstName":"Jennie","lastName":"P. Mather"},{"title":"CEO","started":"2006-05-01","ended":"2008-07-01","firstName":"George","lastName":"F. Schreiner"},{"title":"Vice President, Clinical Research","started":null,"ended":null,"firstName":"Stanford","lastName":"Stewart"}]}
